Virax Biolabs Group Ltd - Ordinary Shares - Class A
NASDAQ:VRAX 3:59:27 PM EDT
| Market Cap (Intraday) | 4.00M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.89 |
| 50-Day MA | $0.94 |
| 200-Day MA | $1.52 |
Virax Biolabs Group Ltd - Ordinary Shares - Class A Stock, NASDAQ:VRAX
Bo'Ness Road Newhouse, Lanarkshire, Scotland ML1 5UH
United Kingdom
Phone: +44.20.7788.7414
Number of Employees: 17
Description
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.